1. | rlmcdonough | |
2. | emh8473 | |
3. | steh3587 | |
4. | redoctober30 | |
5. | yellow31sleeping |
1. | rlmcdonough | |
2. | emh8473 | |
3. | steh3587 | |
4. | redoctober30 | |
5. | yellow31sleeping |
1. | emh8473 03/16/2018 What's the price target? |
2. | emh8473 03/12/2018 Reports positive Phase 1/2 Results of AKCEA-APOCIII-LRx presented at American College of Cardiology Annual S… |
3. | rlmcdonough 03/15/2018 WOWWWWW |
4. | rlmcdonough 03/15/2018 Done? I dont think so |
5. | rlmcdonough 03/26/2018 Drop today |
6. | rlmcdonough 02/27/2018 Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2017 |
7. | emh8473 03/15/2018 Ionis and Akcea Partner to Commercialize Inotersen for hATTR |
8. | redoctober30 07/12/2018 Announces that TEGSEDI has received marketing authorization approval from the European Commission, up 10% |
9. | steh3587 03/15/2018 Should be Running for a couple days imo |
10. | rlmcdonough 01/05/2018 Nice! Akcea Initiates Phase 2b Study of AKCEA-APOCIII-LRx in Patients with Hypertriglyceridemia and Established Cardiovascular Disease |